| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/TID.12355 |
| P698 | PubMed publication ID | 25728936 |
| P50 | author | Carlos Lumbreras | Q56867788 |
| P2093 | author name string | J M Morales | |
| A Andrés | |||
| F López-Medrano | |||
| J M Aguado | |||
| J R de Juanes | |||
| M Fernández-Ruiz | |||
| M P Arrazola | |||
| P2860 | cites work | Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. | Q30380578 |
| An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to [...] | Q30395254 | ||
| Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity. | Q30398841 | ||
| Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort. | Q30401218 | ||
| Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipients. | Q30403135 | ||
| De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients | Q30403833 | ||
| Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients | Q30406140 | ||
| Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients | Q30406926 | ||
| Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study | Q30407134 | ||
| Safety and long-term humoral immune response in adults after vaccination with an H1N1 2009 pandemic influenza vaccine with or without AS03 adjuvant. | Q30412748 | ||
| Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients. | Q30421507 | ||
| Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients | Q30430823 | ||
| Effects of influenza immunization on humoral and cellular alloreactivity in humans | Q36661931 | ||
| Influenza vaccination in the organ transplant recipient: review and summary recommendations. | Q37940524 | ||
| The mechanism of action of MF59 - an innately attractive adjuvant formulation | Q38017390 | ||
| Influenza vaccines in the setting of solid-organ transplantation: are they safe? | Q38019732 | ||
| Influenza vaccination in solid-organ transplant recipients | Q38050048 | ||
| Guidance on novel influenza A/H1N1 in solid organ transplant recipients. | Q39923141 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation | Q42223053 | ||
| Vaccination in solid organ transplantation | Q42272271 | ||
| Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine | Q45744019 | ||
| Influenza vaccination is efficacious and safe in renal transplant recipients | Q46830965 | ||
| Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome. | Q51753855 | ||
| Pancreas rejection after pandemic influenzavirus A(H1N1) vaccination or infection: a report of two cases | Q57105190 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 314-321 | |
| P577 | publication date | 2015-03-02 | |
| P1433 | published in | Transplant Infectious Disease | Q15749562 |
| P1476 | title | Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients | |
| P478 | volume | 17 |
Search more.